Financial Architects (New Jersey)’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,173
Closed -$60K 493
2020
Q2
$60K Buy
1,173
+6
+0.5% +$302 0.01% 393
2020
Q1
$52K Hold
1,167
0.01% 382
2019
Q4
$62K Buy
1,167
+9
+0.8% +$444 0.01% 393
2019
Q3
$54K Hold
1,158
0.01% 427
2019
Q2
$58K Buy
1,158
+3
+0.3% +$148 0.01% 482
2019
Q1
$59K Buy
1,155
+6
+0.5% +$299 0.01% 569
2018
Q4
$54K Buy
1,149
+6
+0.5% +$308 0.01% 526
2018
Q3
$64K Buy
1,143
+3
+0.3% +$164 0.01% 565
2018
Q2
$58K Hold
1,140
0.01% 521
2018
Q1
$56K Buy
1,140
+3
+0.3% +$154 0.01% 581
2017
Q4
$58K Buy
1,137
+6
+0.5% +$308 0.01% 632
2017
Q3
$59K Buy
1,131
+6
+0.5% +$308 0.01% 635
2017
Q2
$58K Hold
1,125
0.01% 625
2017
Q1
$57K Buy
1,125
+3
+0.3% +$149 0.01% 621
2016
Q4
$53K Sell
1,122
-1,041
-48% -$49.4K 0.01% 560
2016
Q3
$108K Hold
2,163
0.03% 378
2016
Q2
$104K Buy
2,163
+6
+0.3% +$285 0.03% 366
2016
Q1
$99K Buy
+2,157
New +$101K 0.04% 278
2015
Q4
Sell
-5,169
Closed -$255K 223
2015
Q3
$255K Buy
5,169
+2,712
+110% +$155K 0.11% 165
2015
Q2
$143K Buy
2,457
+681
+38% +$39.8K 0.05% 238
2015
Q1
$102K Buy
+1,776
New +$97.2K 0.04% 281

Other funds holding IHE

Financial Architects (New Jersey)'s IHE Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2020, closing a stake of 1,173 shares — an estimated $60K sold.

Financial Architects (New Jersey) first reported a position in IHE in Q1 2015 and held it in 21 quarters. The position peaked at $255K in Q3 2015. 94 funds tracked by Wall St. Rank hold IHE as of Q3 2020.

  • Financial Architects (New Jersey) reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2020 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 1,173 iShares US Pharmaceuticals ETF shares in Q3 2020, an estimated $60K.
  • Financial Architects (New Jersey) first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and held it in 21 quarters.
  • Financial Architects (New Jersey)'s iShares US Pharmaceuticals ETF position peaked at $255K in Q3 2015.
  • 94 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.